Cargando…
The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer
The identification of new biomarkers and targets for tailored therapy in human colorectal cancer (CRC) onset and progression is an interesting challenge. CRC tissue produces an excess of ox-LDL, suggesting a close correlation between lipid dysfunction and malignant transformation. Lectin-like oxidiz...
Autores principales: | Murdocca, Michela, Mango, Ruggiero, Pucci, Sabina, Biocca, Silvia, Testa, Barbara, Capuano, Rosamaria, Paolesse, Roberto, Sanchez, Massimo, Orlandi, Augusto, di Natale, Corrado, Novelli, Giuseppe, Sangiuolo, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924750/ https://www.ncbi.nlm.nih.gov/pubmed/26895376 http://dx.doi.org/10.18632/oncotarget.7430 |
Ejemplares similares
-
Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
por: Murdocca, Michela, et al.
Publicado: (2019) -
Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer
por: Murdocca, Michela, et al.
Publicado: (2021) -
Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019) -
LOX-1 and cancer: an indissoluble liaison
por: Murdocca, M., et al.
Publicado: (2021) -
Volatile compounds emission from teratogenic human pluripotent stem cells observed during their differentiation in vivo
por: Capuano, Rosamaria, et al.
Publicado: (2018)